Cardiome Pharma Corp. Company Profile (NASDAQ:CRME)

About Cardiome Pharma Corp.

Cardiome Pharma Corp. (Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company's segments are Europe and Rest of World. Cardiome has two marketed, in-hospital, cardiology products, which include BRINAVESS (vernakalant IV), approved in Europe and other territories for the conversion of onset atrial fibrillation (AF) to sinus rhythm in adults, and AGGRASTAT (tirofiban hydrochloride (HCl)), indicated for use in patients with acute coronary syndrome. Cardiome also commercializes ESMOCARD and ESMOCARD LYO (esmolol hydrochloride), a short-acting beta-blocker used to control heart rate in various cardiovascular indications, in select European markets. Cardiome has also licensed TREVYENT, a development-stage drug device combination product that is under development for pulmonary arterial hypertension, in certain regions outside the United States.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Manufacturers - Other
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: CRME
CUSIP:

Key Metrics:

Previous Close: $3.13
50 Day Moving Average: $3.07
200 Day Moving Average: $4.23
52-Week Range: $2.80 - $9.25
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -10.10
P/E Growth: -0.15
Market Cap: $99.77M
Outstanding Shares: 31,875,000
Beta: 0.99

Profitability:

Net Margins: -96.91%
Return on Equity: -111.18%
Return on Assets: -42.61%

Debt:

Debt-to-Equity Ratio: 1.51%
Current Ratio: 1.40%
Quick Ratio: 1.19%

Additional Links:

Companies Related to Cardiome Pharma Corp.:

Consensus Ratings for Cardiome Pharma Corp. (NASDAQ:CRME) (?)

Ratings Breakdown:	1 Hold Rating, 3 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$8.78 (180.35% upside)

Analysts' Ratings History for Cardiome Pharma Corp. (NASDAQ:CRME)

Show:

Date	Firm	Action	Rating	Price Target
8/15/2016	Brean Capital	Reiterated Rating	Buy	$10.00 -> $7.00
6/1/2016	HC Wainwright	Initiated Coverage	Buy	$9.50
5/6/2016	Mackie	Upgrade	Hold -> Speculative Buy	$5.20 -> $8.60
3/13/2016	Canaccord Genuity	Reiterated Rating	Buy	$10.00
8/14/2015	LB Securities	Reiterated Rating	Buy	$12.50
11/19/2014	Laurentian Bank of Canada	Initiated Coverage	Buy

(Data available from 10/1/2014 forward)

Earnings History for Cardiome Pharma Corp. (NASDAQ:CRME)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/9/2016	Q216	($0.19)	($0.37)	$6.73 million	$5.90 million	View	N/A
5/13/2016	Q116	($0.21)	($0.06)	$6.34 million	$7.10 million	View	Listen
3/10/2016	Q415	($0.19)	($0.37)	$7.74 million	$4.70 million	View	Listen
11/13/2015	Q315	($0.23)	($0.31)	$7.08 million	$5.00 million	View	Listen
8/5/2015	Q215	($0.25)	($0.43)	$7.67 million	$5.70 million	View	N/A
5/13/2015	Q115	($0.28)	($0.23)	$7.48 million	$5.50 million	View	Listen
3/12/2015	Q414	($0.14)	($0.39)	$8.54 million	$7.00 million	View	N/A
11/7/2014	Q314	($0.13)	($0.26)	$6.80 million		View	N/A
8/11/2014		($0.16)	($0.26)			View	N/A
5/12/2014	Q114	($0.11)	($0.20)	$8.08 million	$7.60 million	View	N/A
3/27/2014		($0.22)	($0.53)			View	N/A
11/6/2013	Q3 13	($0.21)	($0.29)			View	N/A
8/2/2013	Q2 13	($0.19)	($0.22)			View	N/A
5/13/2013	Q113	$1.48	$1.47	$1.60 million		View	N/A
3/15/2013	Q412	($0.05)	$0.13	$0.84 million		View	N/A
11/13/2012	Q312	($0.11)	($0.22)			View	N/A
11/4/2011		($0.10)	($0.12)			View	N/A
5/16/2011		($0.11)	($0.12)			View	N/A
3/10/2011		($0.08)	($0.12)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Cardiome Pharma Corp. (NASDAQ:CRME)

Current Year EPS Consensus Estimate: $-0.75 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.14)	($0.13)	($0.14)
Q2 2016	1	($0.24)	($0.24)	($0.24)
Q3 2016	1	($0.30)	($0.30)	($0.30)
Q4 2016	1	($0.24)	($0.24)	($0.24)

(Data provided by Zacks Investment Research)

Dividend History for Cardiome Pharma Corp. (NASDAQ:CRME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cardiome Pharma Corp. (NASDAQ:CRME)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Cardiome Pharma Corp. (NASDAQ:CRME)

Date	Headline
	Investment Analysts' Updated EPS Estimates for June, 1st (AEE ... - DailyQuint (NASDAQ:CRME) dailyquint.com - September 17 at 9:09 AM
	Keen Investors Seek Information on Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME) www.duncanindependent.com - September 17 at 9:09 AM
	Analysts give average Rating of “Buy” to Cardiome Pharma Corp ... - DailyQuint (NASDAQ:CRME) dailyquint.com - September 17 at 9:09 AM
	Stock Update, a Closer Look at Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME) www.duncanindependent.com - September 16 at 8:03 AM
	HC Wainwright Begins Coverage on Cardiome Pharma Corp (CRME) - DailyQuint (NASDAQ:CRME) dailyquint.com - September 16 at 8:03 AM
	Keen Investors Narrowing Their Focus on Cardiome Pharma Corp. (NASDAQ:CRME) - Duncan Research (NASDAQ:CRME) www.duncanindependent.com - September 14 at 9:38 PM
	Shares Gapping Lower Before the Open: Cardiome Pharma Corp. (NASDAQ:CRME) - Post News (NASDAQ:CRME) www.kentuckypostnews.com - September 1 at 4:20 PM
	Cardiome Pharma (CRME) Updates on Recent Insider Transactions; CEO, COO, Others Bought Shares (NASDAQ:CRME) www.streetinsider.com - August 17 at 9:44 AM
	Cardiome Pharma Corp. (NASDAQ: CRME) stock rating reiterated at Brean Capital - BNB Daily (blog) (NASDAQ:CRME) www.baseball-news-blog.com - August 16 at 9:42 PM
	Cardiome Pharma (CRME) Updates on Recent Insider Transactions; CEO, COO, Others Bought Shares - StreetInsider.com (NASDAQ:CRME) www.streetinsider.com - August 16 at 4:29 PM
	Brean Capital Cuts Price Target on Cardiome Pharma (CRME) to $7; Reiterates Buy (NASDAQ:CRME) www.streetinsider.com - August 16 at 8:16 AM
	Cardiome Announces Recent Insider Purchases (NASDAQ:CRME) finance.yahoo.com - August 16 at 8:16 AM
	Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:CRME) www.capitalcube.com - August 11 at 4:31 PM
	Cardiome Pharma : Reports Second Quarter 2016 Financial Results (NASDAQ:CRME) www.4-traders.com - August 9 at 5:24 PM
	Cardiome reports 2Q loss (NASDAQ:CRME) sg.finance.yahoo.com - August 9 at 5:24 PM
	Cardiome Pharma Corporation: Cardiome to Hold Second Quarter 2016 Financial Results Conference Call on August 9 (NASDAQ:CRME) www.twst.com - August 3 at 10:03 PM
	Cardiome Pharma Corporation (CRME) Updated Price Targets - FTSE News (NASDAQ:CRME) www.ftsenews.co.uk - July 29 at 8:16 AM
	Cardiome Pharma Corp (NASDAQ:CRME) Plunge Following Dilution Plans - HotStocked (NASDAQ:CRME) www.hotstocked.com - July 28 at 11:45 AM
	Cardiome Pharma Corp. (NASDAQ:CRME) Unveils $30M Underwritten Public Offering - Journal Transcript (NASDAQ:CRME) www.journaltranscript.com - July 28 at 11:45 AM
	Cardiome Pharma : Announces Pricing of Public Offering of 10,000,000 Common Shares (NASDAQ:CRME) www.4-traders.com - July 27 at 4:28 PM
	New York Community Bank Drops in on Wednesday’s 52-Week Low Club (NASDAQ:CRME) 247wallst.com - July 27 at 4:04 PM
	Mid-Afternoon Market Update: Crude Oil Drops Below $43; Linear Technology Shares Spike Higher - Nasdaq (NASDAQ:CRME) www.nasdaq.com - July 27 at 12:22 PM
	Cardiome Pharma (CRME) Announces Common Stock Offering - StreetInsider.com (NASDAQ:CRME) www.streetinsider.com - July 26 at 12:37 PM
	Biotech Movers: Gilead Sciences, Inc. (NASDAQ:GILD) and CARDIOME PHARMA CORP(NASDAQ:CRME) - Market Exclusive (NASDAQ:CRME) marketexclusive.com - July 26 at 12:37 PM
	Pre-Market Investor's Alert: CARDIOME PHARMA CORP. (NASDAQ:CRME), Special Opportunities Fund Inc. (NYSE:SPE) - Review Fortune (NASDAQ:CRME) reviewfortune.com - July 26 at 12:37 PM
	Cardiome Pharma : Announces Proposed Public Offering of Common Shares (NASDAQ:CRME) www.4-traders.com - July 25 at 9:10 PM
	Cardiome Pharma Corporation Ord (NASDAQ:CRME) Short Interest Decreased By 4.42% - Consumer Eagle (NASDAQ:CRME) www.consumereagle.com - July 20 at 10:50 AM
	How Analysts Rated CARDIOME PHARMA CORP (NASDAQ:CRME) Last Week? - Press Telegraph (NASDAQ:CRME) presstelegraph.com - July 19 at 4:29 PM
	Broker Outlook For Cardiome Pharma Corporation (CRME) - Fiscal Standard (NASDAQ:CRME) www.fiscalstandard.com - July 15 at 10:02 AM
	Cardiome Pharma's (CRME) ESMOCARD and ESMOCARD LYO Approved in Italy - StreetInsider.com (NASDAQ:CRME) www.streetinsider.com - July 14 at 8:19 AM
	Cardiome Pharma Corporation Ord (NASDAQ:CRME) Sellers Increased By 27.09% Their Shorts - Press Telegraph (NASDAQ:CRME) presstelegraph.com - July 14 at 8:19 AM
	Cardiome Pharma Corp (NASDAQ:CRME) Institutional Investors Quarterly Sentiment - Consumer Eagle (NASDAQ:CRME) www.consumereagle.com - July 14 at 8:19 AM
	ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimbursement in Italy (NASDAQ:CRME) finance.yahoo.com - July 14 at 8:00 AM
	Cardiome Pharma Corporation Ord (NASDAQ:CRME) Short Interest Increased By 27.09% - Engelwood Daily (NASDAQ:CRME) www.engelwooddaily.com - July 10 at 4:14 PM
	NYSE, NASDAQ Most Advanced Stocks, July 1 (NASDAQ:CRME) www.fxpips.com - July 4 at 9:15 AM
	Cardiome Pharma Corporation Ord (NASDAQ:CRME) Short Interest Increased By 27.09% - Press Telegraph (NASDAQ:CRME) presstelegraph.com - June 30 at 10:58 AM
	Were Analysts Bearish CARDIOME PHARMA CORP (NASDAQ:CRME) This Week? - Engelwood Daily (NASDAQ:CRME) www.engelwooddaily.com - June 25 at 8:17 AM
	Cardiome Pharma Corporation (CRME) Current Analyst Ratings - Fiscal Standard (NASDAQ:CRME) www.fiscalstandard.com - June 23 at 3:16 PM
	Cardiome Pharma Corp. (NASDAQ:CRME) Upcoming Earnings: What matter for investors? - iStreetWire (NASDAQ:CRME) istreetwire.com - June 9 at 10:27 PM
	H.C. Wainwright Initiates Coverage on CARDIOME PHARMA CORP to Buy - Trade Calls (NASDAQ:CRME) www.tradecalls.org - June 8 at 12:35 PM
	After Last Week What Do Analysts Think Of Cardiome Pharma Corporation (CRME) - Share Trading News (NASDAQ:CRME) www.sharetrading.news - June 5 at 12:09 PM
	Cardiome Pharma Corporation (NASDAQ:CRME) Stock Update & Estimates - Stock Tick Tock (NASDAQ:CRME) www.stockticktock.com - June 3 at 10:34 PM
	Cardiome Pharma Corporation (NASDAQ:CRME) Set To Release Quarterly Earnings - Investor Newswire (NASDAQ:CRME) www.investornewswire.com - June 3 at 12:33 PM
	Share Rating Focus on Cardiome Pharma Corporation (NASDAQ:CRME) - HNN (NASDAQ:CRME) hintsnewsnetwork.com - June 2 at 10:27 PM
	Target Price and Stock Performance Rundown for Cardiome Pharma Corporation (NASDAQ:CRME) - HNN (NASDAQ:CRME) hintsnewsnetwork.com - June 1 at 10:33 PM
	HC Wainwright Begins Coverage on Cardiome Pharma Corp (CRME) - Let Me Know About This (NASDAQ:CRME) www.lmkat.com - June 1 at 11:51 AM
	Coverage initiated on Cardiome Pharma by H.C. Wainwright (NASDAQ:CRME) finance.yahoo.com - June 1 at 7:28 AM
	Recent Investment Analysts' Ratings Changes for Cardiome Pharma Corp (CRME) - Let Me Know About This (NASDAQ:CRME) www.lmkat.com - May 31 at 4:29 PM
	Stock Rating Review for Cardiome Pharma Corporation (NASDAQ:CRME) - Wall Street Hints and News (NASDAQ:CRME) hintsnewsnetwork.com - May 27 at 12:57 PM
	Target Check and Stock Performance Recap Cardiome Pharma Corporation (NASDAQ:CRME) - Wall Street Hints and News (NASDAQ:CRME) hintsnewsnetwork.com - May 26 at 12:03 PM